(NRIM) Northrim BanCorp - Overview
Stock: Commercial Banking, Mortgage Services, Wealth Management
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.84% |
| Yield on Cost 5y | 30.35% |
| Yield CAGR 5y | 8.52% |
| Payout Consistency | 98.4% |
| Payout Ratio | 11.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 39.5% |
| Relative Tail Risk | -8.14% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.52 |
| Alpha | 7.38 |
| Character TTM | |
|---|---|
| Beta | 0.751 |
| Beta Downside | 0.762 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.39% |
| CAGR/Max DD | 0.83 |
Description: NRIM Northrim BanCorp December 27, 2025
Northrim BanCorp Inc. (NASDAQ:NRIM) is a Alaska-based bank holding company that serves businesses and professionals through three operating segments: Community Banking, Home Mortgage Lending, and Specialty Finance. Its product suite spans non-interest-bearing checking, interest-bearing deposits, certificates of deposit, and a full range of commercial and consumer loan products, complemented by a digital banking platform offering online account opening, mobile deposits, and a suite of cash-management tools.
As of Q3 2024, the bank reported a net interest margin of 3.4% and a loan-to-deposit ratio of 78%, both modestly above the regional-bank average, reflecting steady loan growth (≈5% YoY) amid a tightening credit environment. The company’s performance is closely tied to Alaska’s economic backdrop-particularly oil-price volatility and seasonal tourism-which drives both commercial loan demand and deposit inflows. Additionally, the broader regional-bank sector is navigating the Federal Reserve’s higher-for-longer rate policy, which can boost NIM but also pressures credit quality.
For a deeper quantitative view, consider checking ValueRay’s platform for detailed financial metrics and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 64.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 4.10 > 1.0 |
| NWC/Revenue: -660.5% < 20% (prev -1038 %; Δ 377.5% < -1%) |
| CFO/TA 0.04 > 3% & CFO 140.3m > Net Income 64.6m |
| Net Debt (93.6m) to EBITDA (88.8m): 1.05 < 3 |
| Current Ratio: 0.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (22.5m) vs 12m ago 0.63% < -2% |
| Gross Margin: 81.42% > 18% (prev 0.78%; Δ 8065 % > 0.5%) |
| Asset Turnover: 7.66% > 50% (prev 6.44%; Δ 1.22% > 0%) |
| Interest Coverage Ratio: 1.59 > 6 (EBITDA TTM 88.8m / Interest Expense TTM 42.8m) |
Altman Z'' -2.64
| A: -0.49 (Total Current Assets 558.3m - Total Current Liabilities 2.16b) / Total Assets 3.29b |
| B: 0.09 (Retained Earnings 300.7m / Total Assets 3.29b) |
| C: 0.02 (EBIT TTM 67.9m / Avg Total Assets 3.17b) |
| D: 0.11 (Book Value of Equity 326.5m / Total Liabilities 2.96b) |
| Altman-Z'' Score: -2.64 = D |
Beneish M -3.05
| DSRI: 0.80 (Receivables 101.6m/102.2m, Revenue 242.5m/196.0m) |
| GMI: 0.95 (GM 81.42% / 77.53%) |
| AQI: 1.06 (AQ_t 0.82 / AQ_t-1 0.77) |
| SGI: 1.24 (Revenue 242.5m / 196.0m) |
| TATA: -0.02 (NI 64.6m - CFO 140.3m) / TA 3.29b) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
What is the price of NRIM shares?
Over the past week, the price has changed by +9.72%, over one month by -4.40%, over three months by +14.95% and over the past year by +17.48%.
Is NRIM a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NRIM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31 | 19.9% |
| Analysts Target Price | 31 | 19.9% |
| ValueRay Target Price | 34.4 | 32.9% |
NRIM Fundamental Data Overview February 02, 2026
P/E Forward = 12.7714
P/S = 2.4938
P/B = 1.5493
Revenue TTM = 242.5m USD
EBIT TTM = 67.9m USD
EBITDA TTM = 88.8m USD
Long Term Debt = 23.2m USD (from longTermDebt, two quarters ago)
Short Term Debt = 675.0k USD (from shortTermDebt, two quarters ago)
Debt = 93.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 93.6m USD (from netDebt column, last quarter)
Enterprise Value = 157.9m USD (521.0m + Debt 93.6m - CCE 456.7m)
Interest Coverage Ratio = 1.59 (Ebit TTM 67.9m / Interest Expense TTM 42.8m)
EV/FCF = 1.14x (Enterprise Value 157.9m / FCF TTM 138.1m)
FCF Yield = 87.48% (FCF TTM 138.1m / Enterprise Value 157.9m)
FCF Margin = 56.94% (FCF TTM 138.1m / Revenue TTM 242.5m)
Net Margin = 26.64% (Net Income TTM 64.6m / Revenue TTM 242.5m)
Gross Margin = 81.42% ((Revenue TTM 242.5m - Cost of Revenue TTM 45.1m) / Revenue TTM)
Gross Margin QoQ = 82.89% (prev 80.40%)
Tobins Q-Ratio = 0.05 (Enterprise Value 157.9m / Total Assets 3.29b)
Interest Expense / Debt = 11.39% (Interest Expense 10.7m / Debt 93.6m)
Taxrate = 25.09% (4.17m / 16.6m)
NOPAT = 50.9m (EBIT 67.9m * (1 - 25.09%))
Current Ratio = 0.26 (Total Current Assets 558.3m / Total Current Liabilities 2.16b)
Debt / Equity = 0.29 (Debt 93.6m / totalStockholderEquity, last quarter 326.5m)
Debt / EBITDA = 1.05 (Net Debt 93.6m / EBITDA 88.8m)
Debt / FCF = 0.68 (Net Debt 93.6m / FCF TTM 138.1m)
Total Stockholder Equity = 303.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.04% (Net Income 64.6m / Total Assets 3.29b)
RoE = 21.32% (Net Income TTM 64.6m / Total Stockholder Equity 303.0m)
RoCE = 20.81% (EBIT 67.9m / Capital Employed (Equity 303.0m + L.T.Debt 23.2m))
RoIC = 15.18% (NOPAT 50.9m / Invested Capital 335.2m)
WACC = 8.66% (E(521.0m)/V(614.6m) * Re(8.68%) + D(93.6m)/V(614.6m) * Rd(11.39%) * (1-Tc(0.25)))
Discount Rate = 8.68% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.49%
[DCF Debug] Terminal Value 67.28% ; FCFF base≈84.1m ; Y1≈55.2m ; Y5≈25.2m
Fair Price DCF = 15.74 (EV 441.6m - Net Debt 93.6m = Equity 348.0m / Shares 22.1m; r=8.66% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 2.30 | EPS CAGR: -19.18% | SUE: -0.06 | # QB: 0
Revenue Correlation: 98.69 | Revenue CAGR: 20.59% | SUE: 2.57 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.57 | Chg30d=-0.050 | Revisions Net=+2 | Analysts=1
EPS current Year (2026-12-31): EPS=2.59 | Chg30d=-0.220 | Revisions Net=+2 | Growth EPS=+8.8% | Growth Revenue=+1.0%
EPS next Year (2027-12-31): EPS=2.80 | Chg30d=-0.440 | Revisions Net=+0 | Growth EPS=+8.1% | Growth Revenue=+7.4%